After Professor Dun’s daughter, Josie, was tragically diagnosed with DIPG he knew he had to switch his research focus. He says:
“I’ve been solely focused on DIPG research for over five years. I knew I had to take on this particular cancer after my own daughter, Josie, was sadly diagnosed in February 2018, passing away from it in December 2019.
“Even as a cancer researcher myself, it (DIPG) wasn’t really on my radar until Josie was diagnosed. At the time, the only treatment was radiotherapy, something that’s not even remotely specific at tackling such an aggressive cancer.
“I knew I had to get to work. Digging into as much scientific literature as I could, I found the gaps that were missing and wholly committed myself to filling in that area of knowledge, to help prevent or to help other families from going through what mine did.”
“During Josie’s cancer journey, I managed to discover a new combination of therapies, and she was the first patient worldwide to get them. It meant that she lived for nearly two years on those drugs.”